drugset / Trial / NCT00053677

Drug Treatment for Pathologic Gambling Disorder

NCT00053677

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will establish the best dose of the drug naltrexone to treat patients with Pathological Gambling Disorder (PGD) and severe urge symptoms.

Timeline

Start
2002-12
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg
Comparator Naltrexone Small molecule 100 mg
Comparator Naltrexone Small molecule 150 mg

Indications